SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Teladoc Health, Inc. – ‘8-K’ for 3/5/20

On:  Thursday, 3/5/20, at 9:01am ET   ·   For:  3/5/20   ·   Accession #:  1104659-20-29467   ·   File #:  1-37477

Previous ‘8-K’:  ‘8-K’ on 2/27/20 for 2/21/20   ·   Next:  ‘8-K’ on / for 4/14/20   ·   Latest:  ‘8-K’ on / for 2/20/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/05/20  Teladoc Health, Inc.              8-K:7,9     3/05/20   11:30M                                    Toppan Merrill/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     29K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     82K 
11: R1          Cover                                               HTML     49K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 7: XML         XBRL Instance -- tm2011736-1_8k_htm                  XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- tdoc-20200305_lab                     XML     96K 
 5: EX-101.PRE  XBRL Presentations -- tdoc-20200305_pre              XML     64K 
 3: EX-101.SCH  XBRL Schema -- tdoc-20200305                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
 6: ZIP         XBRL Zipped Folder -- 0001104659-20-029467-xbrl      Zip     23K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C:   C:   C:   C:   C:   C: 
 i 0001477449  i false 0001477449 2020-03-04 2020-03-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM  i 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported)  i March 5, 2020

 

 i Teladoc Health, Inc.

(Exact name of registrant as specified in its charter)

 

 i Delaware    i 001-37477    i 04-3705970
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

 i 2 Manhattanville Road,  i Suite 203
 i Purchase,  i New York
   i 10577
(Address of principal executive offices)   (Zip Code)

 

( i 203)  i 635-2002

Registrant’s telephone number, including area code

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
 i Common Stock, par value $0.001 per share    i TDOC    i The New York Stock Exchange

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 i ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 i ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 i ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 i ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company                i ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 C: 

 

 

Item 7.01. Regulation FD.

 

As previously announced, on March 5, 2020, Teladoc Health, Inc. (the “Company”) will host an investor day (the “Investor Day”) in New York City, New York, beginning at 10:00 a.m. Eastern Time. A copy of the materials to be presented by the Company at the Investor Day is furnished herewith as Exhibit 99.1. There will be a live audio webcast of the Investor Day accessible via the Company’s Investor Relations website at http://ir.teladoc.com. The Company reserves the right to discontinue the availability of the materials and webcast at any time.

 

The information furnished under this Item 7.01 of this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
No.
  Description
99.1   Teladoc Health, Inc. slide presentation, dated March 5, 2020.
104   The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TELADOC HEALTH, INC.
   
Date: March 5, 2020 By: /s/ Adam C. Vandervoort
  Name:  Adam C. Vandervoort
  Title: Chief Legal Officer and Secretary

 

 C: 

 

 

 

 C: 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:3/5/204
 List all Filings 
Top
Filing Submission 0001104659-20-029467   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 8:09:59.1am ET